When was Ascilion founded?

Ascilion was founded in 2012 and raised its 1st funding round 9 years after it was founded.

Where is Ascilion located?

Ascilion is headquartered in Stockholm, Sweden.

How many employees does Ascilion have?

As of May 31, 2026, the latest employee count at Ascilion is 13.

Is Ascilion a funded company?

Ascilion is a funded company, having raised a total of $2.23M across 3 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on Jan 01, 2021.

When was the latest funding round of Ascilion?

Ascilion's latest funding was a $***** Series A round on Sep 22, 2025, with participation from 1 investor.

Where does Ascilion rank among its competitors?

Ascilion ranks 7th amongst 82 active competitors, of which 21 are funded. It stands 6th in terms of total funding among its competitors. The most recent competitor to raise funding was Stable Pharma, which secured an undisclosed amount in May, 2026.

Who are the top competitors of Ascilion?

Ascilion's top competitors include Crossject, Xeris Pharmaceuticals and KORU Medical Systems. Among them, Stable Pharma secured the most recent funding round in May, 2026.

Ascilion - 2026 Company Profile, Team, Funding & Competitors

Company Details

Developer of needles for drug delivery and fluid extraction The company has developed a method to extract ISF( interstitial fluid) from a person's skin, using a proprietary array of tiny hollow microneedles. The solution comes with an easy-to-use auto extractor along with a set of detachable consumables for safe ISF collection and handling.

Key Metrics

Founded Year

2012

Location

Stockholm, Sweden

Stage

Series A

Total Funding

$2.23M in 3 rounds

Latest Funding Round

Series A, Sep 22, 2025, $*****

Investors

Nordstjernan & 3 more

Ranked

7^th among 82 active competitors

Employee Count

13 as on May 31, 2026

Similar Companies

KORU Medical Systems & 57 more

View Ascilion's full profile

Ascilion has raised a total funding of $2.23M over 3 rounds. Its first funding round was on Jan 01, 2021. Its latest funding round was a Series A round on Sep 22, 2025 for $*****. 1 investor participated in its latest round. Ascilion has 4 institutional investors.

Here is the list of recent funding rounds of Ascilion:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Sep 22, 2025	6680927	Series A	1355789	7007104	4623393	5969424
Jan 04, 2022	2756534	Seed	7476873	1342580	4620103	Nordstjernan
Jan 01, 2021	7928509	Grant (prize money)	1451628	7332438	7525275	Europa

Access funding benchmarks and valuations. Sign up today!

View details of Ascilion's funding rounds and investors

The founders of Ascilion is Pelle Rangsten.

Here are the details of Ascilion's key team members:

Pelle Rangsten: Co-Founder of Ascilion.
Contact Info: 1 email address

View details of Ascilion's Founder profiles and Board Members

Ascilion's employee count trend

Ascilion has 13 employees as of May 26. Here is Ascilion's employee count trend over the years:

Uncover Ascilion's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Ascilion include Crossject, Xeris Pharmaceuticals and KORU Medical Systems. Here is the list of Top 10 competitors of Ascilion, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Crossject 2001, Dijon (France), Public	Needle-free self-injectable drugs	$40.3M	Rothschild & Co, GSK & 5 others	60/100
2nd	Xeris Pharmaceuticals 2005, Chicago (United States), Public	Developer of liquid-stable injectables for the delivery of drugs	$155M	Redmile Group, Central Texas Angel Network ... & 19 others	60/100
3rd	KORU Medical Systems 1980, City of Orange (United States), Public	Manufacturer of infusion systems and accessories for subcutaneous drug administration	-	-	55/100
4th	Stable Pharma 2011, Bath (United Kingdom), Series B	Developer of technology to store and deliver stable drugs and vaccines	$5M	Ascension, EIC Fund & 78 others	54/100
5th	Owen Mumford 1952, Oxford (United Kingdom), Acquired	Disposables for drug delivery and capillary blood sampling in a variety of therapeutic areas	-	Europa	52/100
6th	Retractable Technologies 1989, Little Elm (United States), Public	Provides portfolio of smart syringes and needles to prevent from needle-stick injuries	-	USAGov	51/100
7th	Ascilion 2012, Stockholm (Sweden), Series A	Developer of needles for drug delivery and fluid extraction	$2.23M	Nordstjernan, Marinvest & 2 others	48/100
8th	Flat Medical 2015, Oakland (United States), Series C	Manufacturer of epidural injection	-	Taiwania Capital, National Development Council ... & 4 others	46/100
9th	Windgap Medical 2011, Boston (United States), Series B	Provider of drug delivery autoinjector for the treatment of anaphylaxis	$76.7M	Taiwania Capital, SKK & 12 others	44/100
10th	Eveon 2009, Montbonnot Saint Martin (France), Seed	Manufacture of connected medical devices focused on the preparation and administration of therapeutic treatment	$4.05M	MEDEVICE, Credit Agricole Alpes Developpement ... & 1 others	42/100